Publication | Open Access

Progression-Free Survival Remains Poor Over Sequential Lines of Systemic Therapy in Patients With BRAF-Mutated Colorectal Cancer

MedicineCancer RecurrencePathologyColorectal CancerImmune Checkpoint InhibitorSystemic TherapyCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentBraf-mutated Colorectal Cancer